Affordable Access

Access to the full text

Virology—the path forward

Authors
  • Rasmussen, Angela L.
  • Gronvall, Gigi K.
  • Lowen, Anice C.
  • Goodrum, Felicia
  • Alwine, James
  • Andersen, Kristian G.
  • Anthony, Simon J.
  • Baines, Joel
  • Banerjee, Arinjay
  • Broadbent, Andrew J.
  • Brooke, Christopher B.
  • Campos, Samuel K.
  • Caposio, Patrizia
  • Casadevall, Arturo
  • Chan, Gary C.
  • Cliffe, Anna R.
  • Collins-McMillen, Donna
  • Connell, Nancy
  • Damania, Blossom
  • Daugherty, Matthew D.
  • And 58 more
Type
Published Article
Journal
Journal of Virology
Publisher
American Society for Microbiology
Publication Date
Jan 03, 2024
Volume
98
Issue
1
Identifiers
DOI: 10.1128/jvi.01791-23
Source
ASM Journals
Keywords
License
Yellow

Abstract

In the United States (US), biosafety and biosecurity oversight of research on viruses is being reappraised. Safety in virology research is paramount and oversight frameworks should be reviewed periodically. Changes should be made with care, however, to avoid impeding science that is essential for rapidly reducing and responding to pandemic threats as well as addressing more common challenges caused by infectious diseases. Decades of research uniquely positioned the US to be able to respond to the COVID-19 crisis with astounding speed, delivering life-saving vaccines within a year of identifying the virus. We should embolden and empower this strength, which is a vital part of protecting the health, economy, and security of US citizens. Herein, we offer our perspectives on priorities for revised rules governing virology research in the US.

Report this publication

Statistics

Seen <100 times